赛诺菲-安万特 SNY 深 沪
已收盘 03-27 16:00:00 美东时间
46.77
+0.170
+0.36%
华盛通- 最 高47.83
- 今 开47.50
- 成交量 344.50万股
- 最 低 43.32
- 昨 收 46.60
- 总市值 1.18亿
- 52周最高 55.73
- 市盈率 静 16.00
- 换手率 136.33%
- 52周最低 43.32
- 委 比 -14.95%
- 总股本 0.03亿
- 历史最高 60.115
- 量 比 1.29
- 振 幅 9.68%
- 历史最低 1.10
- 每 手 1
- 风险率 2.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Semafor Reported Senators Reach Deal On Capping Insulin Costs At $35
https://www.semafor.com/article/03/24/2026/senators-reach-deal-on-capping-insulin-costs-at-35
03-25 18:23
Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst
William Blair starts Eupraxia at Outperform as the analyst flags unmet need and sizable market potential.
03-24 01:59
Dianthus Therapeutics Stock Rallies—Rare Disease Study Success Fuels Optimism
Dianthus Therapeutics shares jump after early success in a Phase 3 trial for CIDP treatment claseprubart, signaling potential progress toward approval.
03-09 21:22
How Do Investors Really Feel About Sanofi SA?
Sanofi SA's (NYSE:SNY) short interest as a percent of float has fallen 5.13% si...
02-27 04:00
'L'Oréal Played a Key Role in Sanofi CEO Ouster, Successor Pick' - Bloomberg
https://www.bloomberg.com/news/articles/2026-02-20/l-oreal-played-a-key-role-in-sanofi-ceo-ouster-successor-pick
02-21 03:24
Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors
Sanofi shares drop after CEO exit and pipeline concerns grow, even as Dupixent sales jump in latest quarter.
02-13 21:23
Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'
Sanofi appoints Belén Garijo as CEO, Paul Hudson's tenure ends on Feb 17, 2026. Garijo will prioritize strengthening R&D and governance.
02-12 19:28
FDA Refuses To Review Moderna's Influenza Shot Application
Moderna stock fell as FDA refused to review its influenza vaccine due to choice of comparator; CEO requests meeting for clarification.
02-11 18:21
Earnings Scheduled For January 29, 2026
Companies Reporting Before The Bell • MOGU (NYSE:MOGU) is estimated to report e...
01-29 19:11
Sanofi Q4 Sales $13.159B Miss $13.410B Estimate
Sanofi (NASDAQ:SNY) reported quarterly sales of $13.159 billion which missed the analyst consensus estimate of $13.410 billion by 1.87 percent. This is a 16.71 percent increase over sales of $11.275 billion the same
01-29 14:39
